Search Results 391-400 of 90896 for Metastasis
Clinical Trials · Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung ...
The primary objective of this study is to determine the safety profile of SX-682 alone and in combination with pembrolizumab in subjects with metastatic ...
... metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety and tolerability and determine RP2D of YH001 ...
The purpose of this study is to determine the safety and tolerability of INCB161734 as a single agent or in combination with other anticancer therapies.
... metastasis and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy. Human Saliva as a Non ...
... metastasis. Research is particularly strong in tumor invasion and metastasis, a key event during tumor progression that accounts for more than 90% of cancer ...
Most patients with papillary thyroid cancer (PTC) present with disease confined to the thyroid; however, neck nodal metastases (NNM) may be found in up to ...
... metastatic carcinoma of the head and neck who have progressed during or after treatment with a platinum containing regimen for recurrent/metastatic disease.
The FDA recently expanded the indication of lutetium Lu 177 vipivotide tetraxetan for PSMA-positive metastatic castration-resistant prostate cancer, ...
Note: The metastases size restriction does not apply to the resected brain metastasis. One brain metastasis must be completely (gross total resection) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.